Cargando…
Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system
Highly efficacious and tolerable treatments that cure hepatitis C viral (HCV) infection exist today, increasing the feasibility of disease elimination. However, large healthcare systems may not be fully prepared for supporting recommended actions due to knowledge gaps, inadequate infrastructure and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532960/ https://www.ncbi.nlm.nih.gov/pubmed/31120906 http://dx.doi.org/10.1371/journal.pone.0216459 |
_version_ | 1783421108534378496 |
---|---|
author | Geboy, Alexander G. Nichols, Whitney L. Fernandez, Stephen J. Desale, Sameer Basch, Peter Fishbein, Dawn A. |
author_facet | Geboy, Alexander G. Nichols, Whitney L. Fernandez, Stephen J. Desale, Sameer Basch, Peter Fishbein, Dawn A. |
author_sort | Geboy, Alexander G. |
collection | PubMed |
description | Highly efficacious and tolerable treatments that cure hepatitis C viral (HCV) infection exist today, increasing the feasibility of disease elimination. However, large healthcare systems may not be fully prepared for supporting recommended actions due to knowledge gaps, inadequate infrastructure and uninformed policy direction. Additionally, the HCV cascade of care is complex, with many embedded barriers, and a significant number of patients do not progress through the cascade and are thus not cured. The aim of this retrospective cohort study was to evaluate a large healthcare system’s HCV screening rates, linkage to care efficiency, and provider testing preferences. Patients born during 1945–1965, not previously HCV positive or tested from within the Electronic Health Record (EHR), were identified given that three-quarters of HCV-infected persons in the United States are from this Birth Cohort (BC). In building this HCV testing EHR prompt, non-Birth Cohort patients were excluded as HCV-specific risk factors identifying this population were not usually captured in searchable, structured data fields. Once completed, the BC prompt was released to primary care locations. From July 2015 through December 2016, 11.5% of eligible patients (n = 9,304/80,556) were HCV antibody tested (anti-HCV), 3.8% (353/9,304) anti-HCV positive, 98.1% (n = 311/317) HCV RNA tested, 59.8% (n = 186/311) HCV RNA positive, 86.6% (161/186) referred and 76.4% (n = 123/161) seen by a specialist, and 34.1% (n = 42/123) cured of their HCV. Results from the middle stages of the cascade in this large healthcare system are encouraging; however, entry into the cascade–HCV testing–was performed for only 11% of the birth cohort, and the endpoint–HCV cure–accounted for only 22% of all infected. Action is needed to align current practice with recommendations for HCV testing and treatment given that these are significant barriers toward elimination. |
format | Online Article Text |
id | pubmed-6532960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-65329602019-06-05 Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system Geboy, Alexander G. Nichols, Whitney L. Fernandez, Stephen J. Desale, Sameer Basch, Peter Fishbein, Dawn A. PLoS One Research Article Highly efficacious and tolerable treatments that cure hepatitis C viral (HCV) infection exist today, increasing the feasibility of disease elimination. However, large healthcare systems may not be fully prepared for supporting recommended actions due to knowledge gaps, inadequate infrastructure and uninformed policy direction. Additionally, the HCV cascade of care is complex, with many embedded barriers, and a significant number of patients do not progress through the cascade and are thus not cured. The aim of this retrospective cohort study was to evaluate a large healthcare system’s HCV screening rates, linkage to care efficiency, and provider testing preferences. Patients born during 1945–1965, not previously HCV positive or tested from within the Electronic Health Record (EHR), were identified given that three-quarters of HCV-infected persons in the United States are from this Birth Cohort (BC). In building this HCV testing EHR prompt, non-Birth Cohort patients were excluded as HCV-specific risk factors identifying this population were not usually captured in searchable, structured data fields. Once completed, the BC prompt was released to primary care locations. From July 2015 through December 2016, 11.5% of eligible patients (n = 9,304/80,556) were HCV antibody tested (anti-HCV), 3.8% (353/9,304) anti-HCV positive, 98.1% (n = 311/317) HCV RNA tested, 59.8% (n = 186/311) HCV RNA positive, 86.6% (161/186) referred and 76.4% (n = 123/161) seen by a specialist, and 34.1% (n = 42/123) cured of their HCV. Results from the middle stages of the cascade in this large healthcare system are encouraging; however, entry into the cascade–HCV testing–was performed for only 11% of the birth cohort, and the endpoint–HCV cure–accounted for only 22% of all infected. Action is needed to align current practice with recommendations for HCV testing and treatment given that these are significant barriers toward elimination. Public Library of Science 2019-05-23 /pmc/articles/PMC6532960/ /pubmed/31120906 http://dx.doi.org/10.1371/journal.pone.0216459 Text en © 2019 Geboy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Geboy, Alexander G. Nichols, Whitney L. Fernandez, Stephen J. Desale, Sameer Basch, Peter Fishbein, Dawn A. Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system |
title | Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system |
title_full | Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system |
title_fullStr | Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system |
title_full_unstemmed | Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system |
title_short | Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system |
title_sort | leveraging the electronic health record to eliminate hepatitis c: screening in a large integrated healthcare system |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532960/ https://www.ncbi.nlm.nih.gov/pubmed/31120906 http://dx.doi.org/10.1371/journal.pone.0216459 |
work_keys_str_mv | AT geboyalexanderg leveragingtheelectronichealthrecordtoeliminatehepatitiscscreeninginalargeintegratedhealthcaresystem AT nicholswhitneyl leveragingtheelectronichealthrecordtoeliminatehepatitiscscreeninginalargeintegratedhealthcaresystem AT fernandezstephenj leveragingtheelectronichealthrecordtoeliminatehepatitiscscreeninginalargeintegratedhealthcaresystem AT desalesameer leveragingtheelectronichealthrecordtoeliminatehepatitiscscreeninginalargeintegratedhealthcaresystem AT baschpeter leveragingtheelectronichealthrecordtoeliminatehepatitiscscreeninginalargeintegratedhealthcaresystem AT fishbeindawna leveragingtheelectronichealthrecordtoeliminatehepatitiscscreeninginalargeintegratedhealthcaresystem |